ACM
Alpha Capital Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.29M | Buy |
28,490
+1,213
| +4% | +$225K | 0.91% | 42 |
|
2025
Q1 | $5.72M | Sell |
27,277
-364
| -1% | -$76.3K | 1.09% | 32 |
|
2024
Q4 | $4.91M | Buy |
27,641
+419
| +2% | +$74.5K | 0.9% | 38 |
|
2024
Q3 | $5.38M | Sell |
27,222
-504
| -2% | -$99.5K | 1.01% | 32 |
|
2024
Q2 | $4.76M | Buy |
27,726
+46
| +0.2% | +$7.89K | 0.93% | 35 |
|
2024
Q1 | $5.04M | Sell |
27,680
-1,709
| -6% | -$311K | 0.98% | 32 |
|
2023
Q4 | $4.55M | Buy |
29,389
+157
| +0.5% | +$24.3K | 0.94% | 35 |
|
2023
Q3 | $4.36M | Sell |
29,232
-1,569
| -5% | -$234K | 1.02% | 27 |
|
2023
Q2 | $4.98M | Hold |
30,801
| – | – | 1.24% | 22 |
|
2023
Q1 | $4.98M | Hold |
30,801
| – | – | 1.24% | 22 |
|
2022
Q4 | $4.98M | Sell |
30,801
-532
| -2% | -$86K | 1.24% | 22 |
|
2022
Q3 | $4.21M | Buy |
31,333
+439
| +1% | +$58.9K | 1.11% | 26 |
|
2022
Q2 | $4.73M | Buy |
30,894
+1,002
| +3% | +$153K | 1.29% | 20 |
|
2022
Q1 | $4.85M | Buy |
29,892
+267
| +0.9% | +$43.3K | 1.05% | 24 |
|
2021
Q4 | $4.01M | Buy |
29,625
+281
| +1% | +$38K | 0.89% | 38 |
|
2021
Q3 | $3.17M | Buy |
29,344
+897
| +3% | +$96.7K | 0.75% | 47 |
|
2021
Q2 | $3.2M | Buy |
28,447
+74
| +0.3% | +$8.34K | 0.75% | 43 |
|
2021
Q1 | $3.07M | Buy |
28,373
+670
| +2% | +$72.5K | 0.78% | 37 |
|
2020
Q4 | $2.97M | Sell |
27,703
-856
| -3% | -$91.7K | 0.75% | 37 |
|
2020
Q3 | $2.5M | Buy |
28,559
+325
| +1% | +$28.5K | 0.72% | 45 |
|
2020
Q2 | $2.77M | Buy |
+28,234
| New | +$2.77M | 0.95% | 35 |
|
2013
Q3 | – | Sell |
-23,267
| Closed | -$962K | – | 80 |
|
2013
Q2 | $962K | Buy |
+23,267
| New | +$962K | 0.9% | 47 |
|